missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Meloxicam 1,0 mg/ml i dimethylsulfoxid, LoGiCal
Description
Meloxicam 1,0 mg/ml i dimethylsulfoxid
Specifications
Specifications
| Kemisk navn eller materiale | Meloxicam |
| CAS | 71125-38-7 |
| Analyt- eller komponentnavne | Meloxicam |
| Forsendelsestilstand | Stuetemperatur |
| Molekylær formel | C14 H13 N3 O4 S2 |
| Certificeringer/compliance | ISO 17034 |
| Synonym | 2 H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, Coxflam, Maxicam, Melonex, Meloxicam, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide |
| InChI formel | InChI=1 S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18 H,1-2H3,(H,15,16,19) |
| SMIL | CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3 |
| IUPAC navn | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ^{6},2-benzothiazin-3-carboxamid |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?